Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2005
09/14/2005EP1572889A2 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
09/14/2005EP1572887A2 Neural regeneration peptide and methods for their use in treatment of brain damage
09/14/2005EP1572885A2 Methods for treating diabetes and other blood sugar disorders
09/14/2005EP1572884A2 Dominant negative variants of methionine aminopeptidase 2 (metap2) and clinical uses thereof
09/14/2005EP1572883A2 Human cytokine receptor
09/14/2005EP1572882A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
09/14/2005EP1572881A2 Tacis and br3 polypeptides and uses thereof
09/14/2005EP1572877A2 Drug metabolizing enzymes
09/14/2005EP1572876A2 Transcriptional regulation of target genes
09/14/2005EP1572875A2 Receptors and membrane-associated proteins
09/14/2005EP1572872A2 Igs as modifiers of the p53 pathway and methods of use
09/14/2005EP1572871A2 T1r3 a novel taste receptor
09/14/2005EP1572869A2 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
09/14/2005EP1572868A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
09/14/2005EP1572867A2 Endothelial cell expression patterns
09/14/2005EP1572865A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/14/2005EP1572864A2 Human serpin polypeptides
09/14/2005EP1572863A2 Method for identifying inhibitors of g protein coupled receptor signaling
09/14/2005EP1572861A2 Ap1 amine oxidase variants
09/14/2005EP1572743A2 Peptides and their use for the treatment of hiv infections
09/14/2005EP1572742A2 Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors
09/14/2005EP1572741A1 Therapeutic and diagnostic agents
09/14/2005EP1572739A1 Asthma susceptibility locus
09/14/2005EP1572735A2 Use of the multifunctional transcription factor yin-yang-1 and variants thereof for treating illnesses, especially type 1 diabetes
09/14/2005EP1572734A1 Peptides impairing pbx dependent gene regulation
09/14/2005EP1572733A1 Inactive transcription factor tif-ia and uses thereof
09/14/2005EP1572728A2 Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
09/14/2005EP1572726A2 4-methylhexanoic kahalalide f compound
09/14/2005EP1572725A1 Novel chi-conotoxin peptides (-i)
09/14/2005EP1572724A2 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
09/14/2005EP1572721A2 Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes
09/14/2005EP1572719A2 Partial peptide mimetics and methods
09/14/2005EP1572713A2 Antisense modulation of acyl-coa synthetase 1 expression
09/14/2005EP1572679A2 Crfr1 selective ligands
09/14/2005EP1572341A2 Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous-aqueous emulsion
09/14/2005EP1572291A2 The use of cytokine able to bind il-18bp and of inhibiting the activity of a second cytokine
09/14/2005EP1572241A1 Oral pharmaceutical compositions comprising cyclosporin
09/14/2005EP1572235A2 Methods of therapy and diagnosis using targeting of cells that express lax
09/14/2005EP1572230A1 Placental alkaline phosphatase to control diabetes
09/14/2005EP1572229A2 Stable therapeutic proteins
09/14/2005EP1572228A2 Method of inducing maturation of dendritic cells and uses therefor
09/14/2005EP1572227A2 Fwd, pp2c1, adk3, cg3860, cdk4, cg7134, eip75b involved in the regulation of energy homeostasis
09/14/2005EP1572226A2 Peptides having a high cysteine content
09/14/2005EP1572224A2 Methods and compositions for inhibiting binding of ige to a high affinity receptor
09/14/2005EP1572168A2 Anti-infarction molecules
09/14/2005EP1572149A2 Immunogenicity of glucan binding protein
09/14/2005EP1572148A1 Cosmetic composition comprising a metalloproteinase inhibitor and a lipopeptide
09/14/2005EP1572134A2 Protein s protects the nervous system from injury
09/14/2005EP1572133A2 Method for identifying modulators of human orexin-2 receptor
09/14/2005EP1572131A2 Antibody therapy
09/14/2005EP1572130A2 Compositions and methods for the treatment of immune related diseases
09/14/2005EP1572128A2 RNA INTERFERENCE MEDIATED INHIBITION OF HIV GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/14/2005EP1572127A2 Enzyme treatment of foodstuffs for celiac sprue
09/14/2005EP1572126A2 Compositions and methods for altering glucose production
09/14/2005EP1572118A2 Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216
09/14/2005EP1572116A2 Compositions and methods for the treatment of immune related diseases
09/14/2005EP1572115A2 Treatment of diseases and conditions mediated by increased phosphorylation
09/14/2005EP1572111A2 Wound care compositions
09/14/2005EP1572106A2 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
09/14/2005EP1572104A2 Induction of apoptosis by hiv-1 infected monocytic cells
09/14/2005EP1572102A2 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5
09/14/2005EP1572101A2 Disease treatment via antimicrobial peptide inhibitors
09/14/2005EP1572100A2 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
09/14/2005EP1572099A2 Screening and therapeutic methods relating to neurogenesis
09/14/2005EP1572098A2 Method of treating snoring and other obstructive breathing disorders
09/14/2005EP1572097A2 Nucleoside derivatives for treating hepatitis c virus infection
09/14/2005EP1572095A2 S-l-2 -deoxynucleosides for the treatment of resistant hbv strains and combination therapies
09/14/2005EP1572093A2 Improved treatment of cancer with glutamine
09/14/2005EP1572091A2 Compositions and methods for the diagnosis and treatment of tumor
09/14/2005EP1572090A2 Cancer vaccine containing cross-species epitopes of telomerase reverse transcriptase
09/14/2005EP1572083A2 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
09/14/2005EP1572082A2 Cancer-linked gene as target for chemotherapy
09/14/2005EP1572080A2 Fgf variants and methods for use thereof
09/14/2005EP1572076A2 Helical peptidomimetics
09/14/2005EP1572072A2 Methods of treating infection by drug resistant bacteria
09/14/2005EP1572071A2 Systems and methods for treating patients with processed lipoaspirate cells
09/14/2005EP1572070A2 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
09/14/2005EP1572069A2 Protective factors against inflammation, burns and noxious stimuli
09/14/2005EP1572066A2 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
09/14/2005EP1572065A2 Method and pharmaceutical composition for the treatment of multiple sclerosis
09/14/2005EP1572064A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration
09/14/2005EP1571970A2 Diagnosis and monitoring of diseases
09/14/2005EP1438060A4 Prevention and treatment of restenosis by local administration of drug
09/14/2005EP1399157B1 Combination comprising a p-gp inhibitor and an anti-epileptic drug
09/14/2005EP1390062A4 Modulators of elastase inhibitor secretion
09/14/2005EP1328656A4 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents
09/14/2005EP1258250B1 Nerve protective drugs
09/14/2005EP1255774B1 Methods for identifying compounds useful for the treatment of obesity involving foxc2
09/14/2005EP1140009B1 Absorbent article composition and use thereof for sequestering skin irritants.
09/14/2005EP1137422B1 Use of human prostate cell lines for the treatment of prostate cancer
09/14/2005EP1082141B1 Cd40 binding antibodies and ctl peptides for treating tumors
09/14/2005EP1077725B1 Topical pharmaceutical compositions useful for treating cutaneous or circulatory pathologies on inflammatory, immune, proliferative or degenerative basis, comprising pollen extract and vegetable oil unsaponifiables
09/14/2005EP1013665B1 Polypeptide having water channel activity and dna sequence
09/14/2005EP0904283B1 Human netrin-1
09/14/2005EP0839204B1 Method for producing haemin proteins using plant cells, resulting proteins and products containing same
09/14/2005EP0813543B1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/14/2005CN1668762A Sgk and Nedd used as diagnostic and therapeutic targets
09/14/2005CN1668758A Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
09/14/2005CN1668754A Carotene synthase gene and uses therefor
09/14/2005CN1668751A Modified adenovirus vectors for use in vaccines and gene therapy
1 ... 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 ... 3163